Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00125-015-3597-5 http://scihub22266oqcxt.onion/10.1007/s00125-015-3597-5 C4499108!4499108!25962521     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetologia 2015 ; 58 (8): 1715-9 Nephropedia Template TP {{tp|p=25962521|t=2015. Vascular AGE-ing by methylglyoxal: the past, the present and the future |pdf=|usr=}}{{25962521}} gab.com Text Vascular AGE-ing by methylglyoxal: the past, the present and the future JO: Diabetologia http://www.kidney.de/pget.php?&tw=1&pmid=25962521 #FOAvip Over the years, new research has elucidated the importance of the very fast formation of AGEs by the highly reactive methylglyoxal (MGO). It has become clear that MGO triggers maladaptive responses in vascular tissue. To counteract the deleterious effects of MGO, organisms have an enzymatic glyoxalase defence system in which MGO is converted to d-lactate, with glyoxalase 1 (GLO1) as the key enzyme in this system. Significant progress has been made towards the understanding of the MGO?GLO1 pathway in the pathogenesis of vascular disease in diabetes. This commentary highlights some lines of current research and future perspectives. The work conducted so far is only the starting point?in the coming 50 years, the MGO?GLO1 pathway will be the subject of intensified research, with special focus on pathophysiological pathways, the use of this system for early screening and risk prediction, and the development of intervention strategies for preventing vascular complications in people with and without diabetes. This is one of a series of commentaries under the banner ?50 years forward?, giving personal opinions on future perspectives in diabetes, to celebrate the 50th anniversary of Diabetologia (1965?2015). Twit Text FOAVip Vascular AGE-ing by methylglyoxal: the past, the present and the future ????Diabetologia http://www.kidney.de/pget.php?&tw=1&pmid=25962521 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25962521 #FOAvip English Wikipedia <ref>{{Cite pmid|25962521}}</ref> Vascular AGE-ing by methylglyoxal: the past, the present and the future #MMPMID25962521 Schalkwijk CG Diabetologia 2015[]; 58 (8): 1715-9 PMID25962521show ga Over the years, new research has elucidated the importance of the very fast formation of AGEs by the highly reactive methylglyoxal (MGO). It has become clear that MGO triggers maladaptive responses in vascular tissue. To counteract the deleterious effects of MGO, organisms have an enzymatic glyoxalase defence system in which MGO is converted to d-lactate, with glyoxalase 1 (GLO1) as the key enzyme in this system. Significant progress has been made towards the understanding of the MGO?GLO1 pathway in the pathogenesis of vascular disease in diabetes. This commentary highlights some lines of current research and future perspectives. The work conducted so far is only the starting point?in the coming 50 years, the MGO?GLO1 pathway will be the subject of intensified research, with special focus on pathophysiological pathways, the use of this system for early screening and risk prediction, and the development of intervention strategies for preventing vascular complications in people with and without diabetes. This is one of a series of commentaries under the banner ?50 years forward?, giving personal opinions on future perspectives in diabetes, to celebrate the 50th anniversary of Diabetologia (1965?2015). äVascular AGE-ing by methylglyoxal: the past, the present and the futur(epmc).pdf DeepDyve Pubget Overpricing